Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis - eBioMedicine
Controls, comparator arms, and designs for critical care comparative effectiveness research: It's complicated - Verity J Ford, Harvey G Klein, Robert L Danner, Willard N Applefeld, Jeffrey Wang, Irene Cortes-Puch, Peter Q
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Most noninferiority trials were not designed to preserve active comparator treatment effects - ScienceDirect
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Innovative Hybrid Designs and Analytical Approaches Leveraging Real-World Data and Clinical Trial Data | SpringerLink
Clinical trial overview. CT Computed tomography, CT group Active... | Download Scientific Diagram
Controls, comparator arms, and designs for critical care comparative effectiveness research: It's complicated - Verity J Ford, Harvey G Klein, Robert L Danner, Willard N Applefeld, Jeffrey Wang, Irene Cortes-Puch, Peter Q
Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Uncontrolled Extensions of Clinical Trials and the Use of External Controls—Scoping Opportunities and Methods - Wang - 2022 - Clinical Pharmacology & Therapeutics - Wiley Online Library
On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Active-comparator design and new-user design in observational studies. - Abstract - Europe PMC
Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer | Scientific Reports
PRS Performance Support Tool
Active-comparator design and new-user design in observational studies. - Abstract - Europe PMC
New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices - Luijken - 2021 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
![PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/59e6f477143222b0341e0568c8f08b26f2d8dc27/5-Figure1-1.png "PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar")
PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar
NCT02257567 (Clinical Trial / Polatuzumab Vedotin / DCDS4501A / RG-7596) | ADC Review
Active-comparator arm - RaDaR
Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials | Journal of the American College of Cardiology
White Paper title goes here
Nutrients | Free Full-Text | Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial
Left: Circuit details of the strong arm latch based comparator. Right:... | Download Scientific Diagram
